COMPOSITION CONTAINING SPIRULININ AND PALMITIOLETHANOLAMIDE AND / OR THEIR APPLICATIONS OR THEIR APPLICATIONS OR THEIR PHARMACEUTICALLY ACCEPTABLE DERIVATIVES AND PREPARATIONS THEREOF, FOR THE APPLICATION IN THE PREVENTION AND / OR TREATMENT OF THEM, AND THE TREATMENT OF THEM, AND THE TREATMENT OF THEM
The claimed invention relates to a composition containing spirulina and palmitoyl ethanolamide (PEA) and / or their pharmaceutically acceptable derivatives or salts, pharmaceutical preparations containing a combination of spirulina and PEA and / or their pharmaceutically acceptable derivatives or salts, in some cases, with at least one physiologically acceptable excipient, and the use of a combination of spirulina and PEA and / or their pharmaceutically acceptable derivatives or salts and pharmaceutical preparations containing the combination in prophylaxis and / or hyperactive tissue syndrome, in the prevention and / or treatment of inflammatory pathologies, in the prevention and / or treatment of changes in coronary and / or cardiac tissues, in the prevention and / or treatment of changes in vascular tissue, in the prevention and / or treatment of changes in ophthalmic pathologies, preferably in prevention and / or treatment of changes in pathologies associated with age-related macular degeneration and glaucoma, in the prevention and / or treatment of dyslipidemia, in the prevention and / or treatment of changes in lung tissue, in prevention / Or treatment of pelvic tissue changes, in the prevention and / or treatment of cell changes due to carcinogenesis and / or in the prevention and / or treatment of dermatological changes.Заявленное изобретение относится к составу, содержащему спирулину и пальмитоилэтаноламид (ПЭА) и/или их фармацевтически приемлемые производные или соли, фармацевтическим препаратам, содержащим сочетание спирулины и ПЭА и/или их фармацевтически приемлемые производные или соли, в некоторых случаях, с как минимум одним физиологически приемлемым эксципиентом, и применению сочетания спирулины и ПЭА и/или их фармацевтически приемлемых производных или солей и фармацевтических препаратов, содержащих данное сочетание, в профилактике и/или лечении синдрома гиперактивированных тканей, в профилактике и/или лечении воспалительных патологий, в профилактике
